Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1987 Dec 11:9 Suppl:S45-7.
doi: 10.1007/BF02075259.

Ciprofloxacin for infection prevention in patients with acute leukemia

Affiliations
Clinical Trial

Ciprofloxacin for infection prevention in patients with acute leukemia

M Rozenberg-Arska et al. Pharm Weekbl Sci. .

Abstract

Ciprofloxacin, a new quinolone derivative, was given prophylactically (500 mg twice daily) to 15 patients with acute leukemia during remission induction treatment. The effect on the microbial flora of the alimentary tract was evaluated. A rapid elimination of Enterobacteriaceae was observed. Bacteriodes and Clostridium species were not affected. Few ciprofloxacin resistant strains were isolated but did not lead to colonization. In a randomized study 56 patients with acute leukemia received either ciprofloxacin or trimethoprim-sulfamethoxazole plus colistin for prevention of infections. Six major infections occurred in 28 patients receiving ciprofloxacin, and 11 major infections in 28 patients receiving trimethoprim-sulfamethoxazole plus colistin. No infections caused by Gram-negative bacilli were seen in the ciprofloxacin group compared to 17 in the other group (p less than 0.02). Ciprofloxacin prevented colonization with resistant Gram-negative bacilli while 12 resistant colonizing strains were isolated from 10 patients receiving trimethoprim-sulfamethoxazole (p less than 0.01). Ciprofloxacin was better tolerated than trimethoprim-sulfamethoxazole + colistin; fewer side effects occurred.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Infect Dis. 1983 Apr;147(4):624-34 - PubMed
    1. J Infect Dis. 1985 Jul;152(1):104-7 - PubMed
    1. Am J Med. 1986 May;80(5):884-90 - PubMed
    1. J Infect Dis. 1983 Apr;147(4):611-4 - PubMed
    1. Ann Intern Med. 1981 Nov;95(5):555-9 - PubMed

Publication types

MeSH terms

LinkOut - more resources